Indian Atovaquone Exporters: Complete Supplier Ranking with Market Share — 17 Manufacturers (2026) — TransData Nexus

Q: Who is the largest atovaquone supplier from India?

MYLAN LABORATORIES LIMITED is the largest atovaquone exporter from India with a 94.3% market share and export value of $934.1M.

Q: How many atovaquone suppliers are there in India?

There are 17 active atovaquone exporters in India, collectively shipping $990.7M worth of atovaquone across 437 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top atovaquone suppliers from India?

The top 5 atovaquone suppliers from India — MYLAN LABORATORIES LIMITED, GLENMARK PHARMACEUTICALS LIMITED, HETERO LABS LIMITED, LUPIN LIMITED, GLENMARK PHARMACEUTICALS LTD — together control 100.0% of total atovaquone export value from India.

Suresh Sormare

Atovaquone

India Pharmaceutical Trade Intelligence

$990.7M17 Suppliers21 CountriesHS 30049099

ExportsIndia → HUNGARY93.7%India → UNITED STATES5.0%

ImportsGERMANY → India$53.1K UNITED STATES → India$34.3K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN HUNGARY

Atovaquone Suppliers from India (2026) — 17 Exporters, $990.7M Market | TransData Nexus | TransData Nexus

Who Exports Atovaquone from India — 17 Suppliers Behind a $990.7M Market

India's atovaquone export market is supplied by 17 active exporters who collectively shipped $990.7M across 437 shipments. MYLAN LABORATORIES LIMITED leads with a 94.3% market share, followed by GLENMARK PHARMACEUTICALS LIMITED and HETERO LABS LIMITED. The top 5 suppliers together control 100.0% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Atovaquone Suppliers & Exporters — 17 manufacturers, $990.7M export market, top destinations and formulations — Atovaquone supplier data — 17 exporters · $990.7M market · 437 shipmentsTransData Nexus · Indian Customs Data

Top Atovaquone Exporters from India — Ranked by Export Value

MYLAN LABORATORIES LIMITED is the leading atovaquone exporter from India, holding a 94.3% share of the $990.7M market across 437 shipments from 17 exporters. The top 5 suppliers — MYLAN LABORATORIES LIMITED, GLENMARK PHARMACEUTICALS LIMITED, HETERO LABS LIMITED, LUPIN LIMITED, GLENMARK PHARMACEUTICALS LTD — collectively control 100.0% of total export value, indicating a highly concentrated market. Individual shares are: MYLAN LABORATORIES LIMITED (94.3%), GLENMARK PHARMACEUTICALS LIMITED (2.8%), HETERO LABS LIMITED (2.2%), LUPIN LIMITED (0.5%), GLENMARK PHARMACEUTICALS LTD (0.1%).

Top Atovaquone Exporters from India

Ranked by export value · 17 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Atovaquone Exporters from India — Ranked by Export Value. 17 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Atovaquone — Export Intelligence Video

Visual overview of India's atovaquone supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's atovaquone pharmaceutical supplier landscape — $990.7M in total trade, 17 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Atovaquone exporters

Certification and compliance status for top Atovaquone suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
MYLAN LABORATORIES LIMITED	Approved	Yes, valid until Dec	Not Listed	Not verified	FDA approval and WHO-GMP certification valid through December 2023.
GLENMARK PHARMACEUTICALS LIMITED	Warning Letter, July 2025	Not Listed	Not Listed	Not verified	FDA issued a warning letter in July 2025 for the Madhya Pradesh facility.
HETERO LABS LIMITED	Approved	Yes	Yes	Not verified	Hetero Labs holds FDA approval, WHO-GMP, and EU GMP certifications.
LUPIN LIMITED	Approved	Yes	Yes	Not verified	Lupin Limited maintains FDA approval, WHO-GMP, and EU GMP certifications.
YASHICA PHARMACEUTICALS PRIVATE LIMITED	Not Listed	Yes	Not Listed	Not verified	WHO-GMP certified; no FDA listing found.
LIVEALTH BIOPHARMA PRIVATE LIMITED	Not Listed	Yes	Not Listed	Not verified	WHO-GMP certified; no FDA listing found.
KALINDI OVERSEAS	Not Listed	Yes	Not Listed	Not verified	WHO-GMP certified; no FDA listing found.
3S PHARMACEUTICALS INDIA PRIVATE LIMITED	Not Listed	Yes	Not Listed	Not verified	WHO-GMP certified; no FDA listing found.
P.B.P ENTERPRISES PRIVATE LIMITED	Not Listed	Yes	Not Listed	Not verified	WHO-GMP certified; no FDA listing found.

TransData Nexus reviewed the regulatory standing of 9 leading Atovaquone exporters from India. 3 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 2 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Atovaquone sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," hosts over 800 pharmaceutical companies, including major players like Dr. Reddy’s Laboratories, Aurobindo Pharma, and Divi’s Laboratories. The city is renowned for its production of Active Pharmaceutical Ingredients (APIs) and has a robust infrastructure supporting pharmaceutical manufacturing. Notably, Hetero Labs Limited, one of the top exporters of Atovaquone, is headquartered in Hyderabad, underscoring the city's pivotal role in the production and export of this antiprotozoal medication.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is a significant hub for pharmaceutical formulations, contributing nearly 28% of India's pharmaceutical production. This region is home to leading companies such as Zydus Cadila, Intas Pharmaceuticals, and Torrent Pharmaceuticals. The presence of manufacturers like Shreeji Pharma International in Vadodara, which specializes in Atovaquone production, highlights the area's capacity for both API and finished dosage form manufacturing.

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Atovaquone exporters from India

October 2023

Divestiture

Viatris Inc. (formerly Mylan Laboratories Limited) — Viatris divests multiple business units for $3.6 billion

In October 2023, Viatris reached agreements to divest nearly all of its over-the-counter (OTC) business, women's healthcare business, and its India-based active pharmaceutical ingredients (API) business for approximately $3.6 billion. - IMPACT: This divestiture may lead to a strategic realignment, potentially affecting Viatris's focus on Atovaquone production and export capabilities.

Impact: This divestiture may lead to a strategic realignment, potentially affecting Viatris's focus on Atovaquone production and export capabilities.

December 2024

Regulatory

Viatris Inc. (formerly Mylan Laboratories Limited) — FDA issues warning letter and import alert to Viatris's Indore facility

In late December 2024, the U.S. FDA issued a warning letter and an import alert concerning Viatris's manufacturing facility in Indore, India. The alert affects 11 actively distributed products, which will no longer be accepted into the U.S. until the issues are resolved. The violations cited include subpar quality control and improper management of manufacturing defects. - IMPACT: This regulatory action could disrupt Viatris's Atovaquone exports to the U.S., potentially impacting supply chains and market availability.

Common Questions — Atovaquone Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which atovaquone supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, MYLAN LABORATORIES LIMITED leads with 58 recorded shipments worth $934.1M. GLENMARK PHARMACEUTICALS LIMITED (177 shipments) and HETERO LABS LIMITED (137 shipments) are also established high-volume exporters.

Q How many atovaquone manufacturers are there in India?

India has 17 active atovaquone exporters with a combined export market of $990.7M across 437 shipments to 21 countries. The top 5 suppliers hold 100.0% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for atovaquone from India?

Average FOB unit price: $40.71 per unit, ranging from $0.02 to $238.72. Average shipment value: $2.3M.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Atovaquone

Atovaquone

Who Exports Atovaquone from India — 17 Suppliers Behind a $990.7M Market

Top Atovaquone Exporters from India — Ranked by Export Value

Top Atovaquone Exporters from India

Related Analysis

Need Details?

Atovaquone — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Viatris Inc. (formerly Mylan Laboratories Limited) — Viatris divests multiple business units for $3.6 billion

Viatris Inc. (formerly Mylan Laboratories Limited) — FDA issues warning letter and import alert to Viatris's Indore facility

Common Questions — Atovaquone Suppliers from India

Q Which atovaquone supplier from India is the most reliable for bulk orders?

Q How many atovaquone manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for atovaquone from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Glenmark Pharmaceuticals Limited — Glenmark sells 75% stake in Glenmark Life Sciences to Nirma Limited

Analysis Methodology